 
        Safety and Efficacy of Tranexamic Acid in Patients Undergoing Thoracic Spine Stenosis Surgery
 
                                                    Safety and Efficacy of Tranexamic Acid in Patients Undergoing Thoracic Spine Stenosis Surgery
The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial
BMC Musculoskelet Disord . 2022 May 2;23(1):410.Synopsis
Sixty-eight patients who were undergoing surgery for multilevel thoracic spine stenosis were randomized to receive tranexamic acid (TXA) or placebo during their surgery. The primary outcomes of this trial were to determine the total blood lost intraoperatively and perioperatively. Other outcomes such as the need for a blood transfusion, blood coagulation function, and length of hospital stay were ...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.